News Agency

Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study

  • Written by PR Newswire
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study

MELBOURNE, Australia and SAN FRANCISCO, Oct. 27, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced it has commenced enrolling patients with Multiple System Atrophy (MSA) in its bioMUSE Study in the United States.

BioMUSE is a natural history study that aims to track the progression of...

Read more: Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study

AMOLED Display Technology: Advantages and Applications

Introduction AMOLED (Active Matrix Organic Light-Emitting Diode, active matrix organic light-emitting diode) display technology is one of the important innovations in today’s display field. Compared with traditional LCD (liquid crystal display), AMOLED displays have many unique advantages and have been widely... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion